Intermountain, Stanford, precision medicine specialist join forces on Oncology Precision Network to boost Joe Biden's Cancer Moonshot
Intermountain Healthcare, Stanford Cancer Institute, Providence Health and Services, and precision medicine company Syapse aligned to advance cancer care through data sharing and better access to clinical trials.
The collaborating organizations created the Oncology Precision Network in response to Vice President Joe Biden’s Cancer Moonshot Initiative. OPN is designed to share aggregated clinical, molecular, and treatment data through a software platform.
Collectively, the OPN will use the Syapse technology to link aggregated data between the geographically disparate health systems. Syapse president Jonathan Hirsch said in a statement that the consortium aims to turn the Cancer Moonshot vision into reality for patients.
The goal is to bring the most promising treatment insights to cancer patients and physicians as rapidly as possible and to discover breakthroughs in cancer care by leveraging the 100,000 data sets anticipated to populate OPN’s database in immediate future.
The group comprises data and physicians across 11 states, 79 hospitals and 800 clinics and when fully implemented the OPN will impact 50,000 new cancer patients per year and have more than 1.5 million historical cancer cases.
“This consortium exists because we all arrived at the same important conclusion: We need to collaborate across health systems to cure cancer,” added Lincoln Nadauld, MD, executive director of Intermountain Precision Genomics. “Through collaboration, we emphasize the need to learn together to empower physicians and patients in finding solutions to cancer without increasing costs.”